Viking Global Investors Portfolio holdings
AUM
$34.6B
1-Year Return
30.14%
This Quarter Return
-2.73%
1 Year Return
+30.14%
3 Year Return
+120.76%
5 Year Return
+143.03%
10 Year Return
+428.26%
AUM
$24.6B
AUM Growth
+$216M
(+0.88%)
Cap. Flow
+$629M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
42.53%
Holding
101
New
15
Increased
31
Reduced
21
Closed
21
Top Buys
| 1 |
United Parcel Service
UPS
|
+$900M |
| 2 |
Microsoft
MSFT
|
+$575M |
| 3 |
Amazon
AMZN
|
+$553M |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$545M |
| 5 |
Workday
WDAY
|
+$472M |
Top Sells
| 1 |
Elevance Health
ELV
|
+$628M |
| 2 |
Sherwin-Williams
SHW
|
+$604M |
| 3 |
Intuit
INTU
|
+$483M |
| 4 |
Arista Networks
ANET
|
+$330M |
| 5 |
Philip Morris
PM
|
+$285M |
Sector Composition
| 1 | Healthcare | 28.63% |
| 2 | Technology | 19.74% |
| 3 | Financials | 16.17% |
| 4 | Industrials | 13.83% |
| 5 | Consumer Discretionary | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Dover
DOV
$23.7B
| $74.9M | 0.3% |
+536,587
| New | +$74.9M |
|
52
NewAmsterdam Pharma
NAMS
$2.72B
| $74.2M | 0.3% |
8,024,565
+1,500,000
| +23% | +$13.9M |
|
53
Coupang
CPNG
$59.1B
| $74.2M | 0.3% |
4,362,544
-10,952,661
| -72% | -$186M |
|
54
Keurig Dr Pepper
KDP
$37B
| $72.2M | 0.29% |
+2,288,261
| New | +$72.2M |
|
55
KE Holdings
BEKE
$23.7B
| $71.7M | 0.29% |
+4,620,000
| New | +$71.7M |
|
56
Tenet Healthcare
THC
$17B
| $67.6M | 0.27% |
1,025,840
+662,040
| +182% | +$43.6M |
|
57
Pharvaris
PHVS
$1.49B
| $67.5M | 0.27% |
3,231,923
| – | – |
|
|
GTM
58
ZoomInfo Technologies
GTM
$3.72B
| $61.6M | 0.25% |
3,754,192
+2,519,654
| +204% | +$41.3M |
|
59
4D Molecular Therapeutics
FDMT
$318M
| $61M | 0.25% |
4,787,914
| – | – |
|
60
Datadog
DDOG
$47.6B
| $60.9M | 0.25% |
668,511
-211,367
| -24% | -$19.3M |
|
61
Zai Lab
ZLAB
$3.65B
| $60.6M | 0.25% |
2,491,003
-138,442
| -5% | -$3.37M |
|
62
Confluent
CFLT
$6.63B
| $58.7M | 0.24% |
+1,983,066
| New | +$58.7M |
|
63
Boston Scientific
BSX
$152B
| $58.6M | 0.24% |
+1,110,292
| New | +$58.6M |
|
64
Amylyx Pharmaceuticals
AMLX
$1.04B
| $54.2M | 0.22% |
2,962,555
| – | – |
|
65
Viking Therapeutics
VKTX
$2.79B
| $50.6M | 0.21% |
4,573,316
+1,028,810
| +29% | +$11.4M |
|
66
Mobileye
MBLY
$11.1B
| $42M | 0.17% |
+1,011,692
| New | +$42M |
|
67
Dollar General
DG
$23B
| $39M | 0.16% |
+368,172
| New | +$39M |
|
|
FL
68
DELISTED
Foot Locker
FL
| $38.8M | 0.16% |
+2,235,456
| New | +$38.8M |
|
69
Edgewise Therapeutics
EWTX
$1.5B
| $35.3M | 0.14% |
6,159,146
+215,885
| +4% | +$1.24M |
|
70
Arm
ARM
$160B
| $32.1M | 0.13% |
+600,000
| New | +$32.1M |
|
71
Day One Biopharmaceuticals
DAWN
$729M
| $31.4M | 0.13% |
2,558,563
| – | – |
|
|
FTCH
72
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $22.7M | 0.09% |
10,844,009
+6,074,407
| +127% | +$12.7M |
|
73
Verastem
VSTM
$598M
| $20M | 0.08% |
2,456,292
+570,000
| +30% | +$4.63M |
|
74
Rallybio
RLYB
$25.1M
| $14.1M | 0.06% |
4,194,777
| – | – |
|
75
Trevi Therapeutics
TRVI
$1B
| $9.59M | 0.04% |
4,400,000
| – | – |
|